Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.

Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM.

J Neurosci. 2012 Jan 18;32(3):841-9. doi: 10.1523/JNEUROSCI.4461-11.2012.

2.

Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.

Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.

Arch Gen Psychiatry. 2007 Aug;64(8):932-40.

PMID:
17679638
3.

Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.

Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A.

Neuroimage. 2005 Apr 15;25(3):868-76.

PMID:
15808987
4.

Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.

Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J.

Eur Neuropsychopharmacol. 2013 Dec;23(12):1714-23. doi: 10.1016/j.euroneuro.2013.05.002. Epub 2013 May 31.

PMID:
23731497
5.

Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.

Wang GJ, Volkow ND, Wigal T, Kollins SH, Newcorn JH, Telang F, Logan J, Jayne M, Wong CT, Han H, Fowler JS, Zhu W, Swanson JM.

PLoS One. 2013 May 15;8(5):e63023. doi: 10.1371/journal.pone.0063023. Print 2013.

6.

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.

Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM.

Am J Psychiatry. 2004 Jul;161(7):1173-80.

PMID:
15229048
7.

Mechanism of action of methylphenidate: insights from PET imaging studies.

Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ.

J Atten Disord. 2002;6 Suppl 1:S31-43.

PMID:
12685517
8.

Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.

Quinn D.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S62-6. doi: 10.1097/JCP.0b013e3181744aa6. Review.

PMID:
18480679
9.

A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.

del Campo N, Fryer TD, Hong YT, Smith R, Brichard L, Acosta-Cabronero J, Chamberlain SR, Tait R, Izquierdo D, Regenthal R, Dowson J, Suckling J, Baron JC, Aigbirhio FI, Robbins TW, Sahakian BJ, Müller U.

Brain. 2013 Nov;136(Pt 11):3252-70. doi: 10.1093/brain/awt263.

10.

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.

Volkow ND, Wang GJ, Fowler JS, Ding YS.

Biol Psychiatry. 2005 Jun 1;57(11):1410-5. Epub 2005 Jan 12. Review.

PMID:
15950015
11.

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D.

J Neurosci. 2001 Jan 15;21(2):RC121.

12.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
13.
14.

Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.

Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C.

Arch Gen Psychiatry. 2006 Dec;63(12):1386-95.

PMID:
17146013
15.

Is increased D2 receptor availability associated with response to stimulant medication in ADHD.

Ilgin N, Senol S, Gucuyener K, Gokcora N, Sener S.

Dev Med Child Neurol. 2001 Nov;43(11):755-60.

16.

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate.

Buitelaar JK, Casas M, Philipsen A, Kooij JJ, Ramos-Quiroga JA, Dejonckheere J, van Oene JC, Schäuble B.

Psychol Med. 2012 Jan;42(1):195-204. doi: 10.1017/S0033291711000845. Epub 2011 Jun 1.

17.

Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.

Wang LJ, Chen CK, Huang YS.

J Child Adolesc Psychopharmacol. 2015 Apr;25(3):246-53. doi: 10.1089/cap.2014.0015. Epub 2015 Jan 9.

PMID:
25574708
18.

Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.

Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH.

Arch Gen Psychiatry. 2012 Sep;69(9):952-61. doi: 10.1001/archgenpsychiatry.2011.2053.

PMID:
22945622
19.

Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.

Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS.

J Clin Psychiatry. 2008 Dec;69(12):1938-47. Epub 2008 Dec 2.

PMID:
19192455
20.

Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.

Schweren LJ, Hartman CA, Zwiers MP, Heslenfeld DJ, van der Meer D, Franke B, Oosterlaan J, Buitelaar JK, Hoekstra PJ.

Eur Child Adolesc Psychiatry. 2015 Aug;24(8):959-68. doi: 10.1007/s00787-014-0645-5. Epub 2014 Nov 14.

PMID:
25395383

Supplemental Content

Support Center